206 related articles for article (PubMed ID: 22694820)
1. Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.
Brait M; Loyo M; Rosenbaum E; Ostrow KL; Markova A; Papagerakis S; Zahurak M; Goodman SM; Zeiger M; Sidransky D; Umbricht CB; Hoque MO
Epigenetics; 2012 Jul; 7(7):710-9. PubMed ID: 22694820
[TBL] [Abstract][Full Text] [Related]
2. Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma.
Mohammadi-asl J; Larijani B; Khorgami Z; Tavangar SM; Haghpanah V; Kheirollahi M; Mehdipour P
Med Oncol; 2011 Dec; 28(4):1123-8. PubMed ID: 20535589
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of promoter methylation profiles in thyroid neoplasms.
Hoque MO; Rosenbaum E; Westra WH; Xing M; Ladenson P; Zeiger MA; Sidransky D; Umbricht CB
J Clin Endocrinol Metab; 2005 Jul; 90(7):4011-8. PubMed ID: 15840741
[TBL] [Abstract][Full Text] [Related]
4. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.
Hu S; Liu D; Tufano RP; Carson KA; Rosenbaum E; Cohen Y; Holt EH; Kiseljak-Vassiliades K; Rhoden KJ; Tolaney S; Condouris S; Tallini G; Westra WH; Umbricht CB; Zeiger MA; Califano JA; Vasko V; Xing M
Int J Cancer; 2006 Nov; 119(10):2322-9. PubMed ID: 16858683
[TBL] [Abstract][Full Text] [Related]
5. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy.
Santoro A; Pannone G; Carosi MA; Francesconi A; Pescarmona E; Russo GM; Feola A; Losito S; Franco R; Nappi L; Aquino G; De Rosa G; Di Domenico M; Bufo P
J Cell Biochem; 2013 May; 114(5):1174-82. PubMed ID: 23192464
[TBL] [Abstract][Full Text] [Related]
7. Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.
Xing M; Cohen Y; Mambo E; Tallini G; Udelsman R; Ladenson PW; Sidransky D
Cancer Res; 2004 Mar; 64(5):1664-8. PubMed ID: 14996725
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status.
Khan MS; Pandith AA; Masoodi SR; Wani KA; Ul Hussain M; Mudassar S
Endocrine; 2014 Nov; 47(2):449-55. PubMed ID: 24927793
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF
Khatami F; Larijani B; Heshmat R; Nasiri S; Haddadi-Aghdam M; Teimoori-Toolabi L; Tavangar SM
J Cell Physiol; 2020 Oct; 235(10):6954-6968. PubMed ID: 32017063
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors.
Nakamura N; Carney JA; Jin L; Kajita S; Pallares J; Zhang H; Qian X; Sebo TJ; Erickson LA; Lloyd RV
Lab Invest; 2005 Sep; 85(9):1065-75. PubMed ID: 15980887
[TBL] [Abstract][Full Text] [Related]
12. Frequency assessment of BRAF mutation, KRas mutation, and RASSF1A methylation in nodular goitre based on fine-needle aspiration cytology specimens Ocena częstości występowania mutacji genów BRAF, KRas oraz.
Koziołek M; Bińczak-Kuleta A; Stepaniuk M; Parczewski M; Andrysiak-Mamos E; Sieradzka A; Safranow K; Osowicz-Korolonek L; Kiedrowicz B; Kram A; Ciechanowicz A; Syrenicz A
Endokrynol Pol; 2015; 66(5):384-93. PubMed ID: 26457492
[TBL] [Abstract][Full Text] [Related]
13. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
14. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
[TBL] [Abstract][Full Text] [Related]
17. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
[TBL] [Abstract][Full Text] [Related]
19. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection.
Zhong X; Isharwal S; Naples JM; Shiff C; Veltri RW; Shao C; Bosompem KM; Sidransky D; Hoque MO
PLoS One; 2013; 8(3):e59089. PubMed ID: 23527093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
